Skip to content
desloratadine

Structure via PubChem · Public domain (PubChem)

EntityQ418060· pop 32· linked from 474 articles

desloratadine

Sign in to save

Also known as SCH-34117, descarboethoxyloratadine, 8-chloro-6,11-dihydro-11-(4-piperidinylidene)-5H-benzo[5,6]cyclohepta[1,2-b]pyridine, 8-chloro-11-piperidin-4-ylidene-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine

Desloratadine, sold under the brand name Aerius among others, is a tricyclic H1 inverse agonist that is used to treat allergies. It is the major active metabolite of loratadine.

Key facts

Drug.verifiedrevid
460777963
Drug.image
Desloratadine.svg
Drug.image_class
skin-invert-image
Drug.width
222
Drug.image2
Desloratadine 3D ball-and-stick.png
Drug.image_class2
bg-transparent
Drug.tradename
Aerius, others
Drug.MedlinePlus
a602002
Drug.DailyMedID
Desloratadine
Drug.pregnancy_AU
B1
Drug.routes_of_administration
By mouth
Drug.class
Second-generation antihistamine
Drug.ATC_prefix
R06
Drug.ATC_suffix
AX27
Drug.legal_AU
S2
Drug.legal_CA
OTC
Drug.legal_UK
POM
Drug.legal_US
Rx-only

via Wikipedia infobox

Chemical data

Formula
C19H19ClN2
Molecular weight
310.8 g/mol
IUPAC name
13-chloro-2-piperidin-4-ylidene-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaene
SMILES
C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
InChIKey
JAUOIFJMECXRGI-UHFFFAOYSA-N
XLogP
4.5
Polar surface area
24.9 Ų
H-bond donors
1
H-bond acceptors
2
Formal charge
0

via PubChem

~4 min read

Encyclopedic overview

9 sections
Contents
  • Medical uses
  • Side effects
  • Interactions
  • Pharmacology
  • Pharmacodynamics
  • Pharmacokinetics
  • Pharmacogenomics
  • References
  • Further reading

Desloratadine, sold under the brand name Aerius among others, is a tricyclic H1 inverse agonist that is used to treat allergies. It is the major active metabolite of loratadine.

It was patented in 1984 and came into medical use in 2001. It was brought to the market in the US by Schering Corporation, later named Schering-Plough.

Excerpted from Wikipedia’s “desloratadine” article, available under the CC BY-SA 4.0 licence.

Gallery (3)